Last10K.com

Heska Corp (HSKA) SEC Filing 10-Q Quarterly report for the period ending Tuesday, June 30, 2020

Heska Corp

HISTORY TOOLS
CIK: 1038133 Ticker: HSKA

Exhibit 99.1
Heska Corporation
heskalogoa051.jpg
Jon Aagaard
Investor Relations
970.619.3033
investorrelations@heska.com
  
Heska Corporation Reports Second Quarter 2020 Results
Record Quarterly Revenues Up 62.4% to $45.7 Million
Reaffirms 2020 Consolidated Revenues and Other Key Targets
LOVELAND, CO, August 4, 2020 -- Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its second quarter ended June 30, 2020. The Company forecast provided in the May 7, 2020 release is referred to as "2020 Combined Outlook". As a result of the Company's reporting segments structure change outlined in this release, the Company is providing a recast of 2020 Combined Outlook full year guidance ("2020 Recast Outlook"). Point of Care is "POC" and scil animal care company GmbH is "scil" in this release.
Second Quarter 2020 and Year Over Year ("YOY") Metrics
$ in millions except Earnings Per Share ("EPS")

Q2 ($)Q2 (%) YOY
Consolidated Revenue$45.762.4%
North America Revenue$29.09.8%
International Revenue$16.7
1
Q2 (%)
Q2 YOY bps2
Consolidated Gross Margin39.1%-500
Q2Q2 (%) YOY
Net loss attributable to Heska$(6.4)
1
Adjusted EBITDA Margin3
9.1%2.7%
EPS, Diluted$(0.72)
1
Non-GAAP EPS, Diluted3
$0.00(100.0)%
1 Comparable percentage variances are not meaningful. 2 "bps" is basis points. 3 See “Use of Non-GAAP Financial Measures” and related reconciliations provided below.
Second Quarter 2020 Highlights
•Revenue benefited by growth in Heska Point of Care Lab Consumables and the recently completed scil acquisition.
•As anticipated, consolidated gross margin was impacted by acquired lower scil margin. Year over year, North America quarterly sales rose 9.8% at a steady 44.0% gross margin and International sales and gross margin met the Company's targets.

The following information was filed by Heska Corp (HSKA) on Tuesday, August 4, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Heska Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Heska Corp.

Continue

Assess how Heska Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Heska Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Earnings
Income
Debt
Product
Expense
Cash Flow
Geography
Shares
Other
Inside Heska Corp's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Capital Stock - Additional Information (Details)
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Income
Condensed Consolidated Statements Of Income
Condensed Consolidated Statements Of Stockholders' Equity
Accrued Liabilities
Accrued Liabilities (Details)
Accrued Liabilities (Tables)
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Details)
Accumulated Other Comprehensive Income (Tables)
Acquisition And Related Party Items
Acquisition And Related Party Items - Additional Information (Details)
Acquisition And Related Party Items - Fair Value Of Assets And Liabilities At Cvm Acquisition Date (Details)
Acquisition And Related Party Items - Fair Values Of Assets And Liabilties At Scil Acquisition Date (Details)
Acquisition And Related Party Items - Intangible Assets Acquired, Amortization Method (Details)
Acquisition And Related Party Items - Unaudited Pro Forma Financial Information (Details)
Acquisition And Related Party Items Acquisition And Related Party Items (Tables)
Capital Stock
Capital Stock (Tables)
Capital Stock - Stock Options And Restricted Stock (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Notes And Credit Facility
Convertible Notes And Credit Facility (Tables)
Convertible Notes And Credit Facility - Carrying Amount Of Debt (Details)
Convertible Notes And Credit Facility - Convertible Notes Narrative (Details)
Convertible Notes And Credit Facility - Credit Facility Narrative (Details)
Convertible Notes And Credit Facility - Interest Expense (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Goodwill And Other Intangibles
Goodwill And Other Intangibles (Details)
Goodwill And Other Intangibles (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Interest And Other Expense, Net
Interest And Other Expense, Net (Details)
Interest And Other Expense, Net (Tables)
Inventories, Net
Inventories, Net (Details)
Inventories, Net (Tables)
Investments In Unconsolidated Affiliates
Investments In Unconsolidated Affiliates (Details)
Investments In Unconsolidated Affiliates (Tables)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Lessee Accounting (Details)
Leases - Lessor Accounting (Details)
Leases - Operating And Financing Lease Balances (Details)
Leases - Supplemental Cash Flow Information (Details)
Leases - Weighted Average Remaining Lease Term And Weighted Average Discount Rate (Details)
Operations And Summary Of Significant Accounting Policies
Operations And Summary Of Significant Accounting Policies (Policies)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Revenue
Revenue (Details)
Revenue (Tables)
Revenue - Performance Obligations (Details)
Segment Reporting
Segment Reporting (Details)
Segment Reporting (Tables)
Segment Reporting - Narrative (Details)
Ticker: HSKA
CIK: 1038133
Form Type: 10-Q Quarterly Report
Accession Number: 0001038133-20-000069
Submitted to the SEC: Mon Aug 10 2020 11:56:47 AM EST
Accepted by the SEC: Mon Aug 10 2020
Period: Tuesday, June 30, 2020
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/hska/0001038133-20-000069.htm